Short Antibiotic Courses Yield Comparable Outcomes in Pneumonia
Overview
A multicenter observational study found that shorter antibiotic courses (3-4 days) in hospitalized patients with community-acquired pneumonia who achieved clinical stability by day 3 resulted in similar outcomes compared to longer courses. Mortality was under 1% in both groups, with comparable rates of readmission, urgent healthcare visits, and Clostridioides difficile infection.
Background
Community-acquired pneumonia is commonly treated with antibiotics, but optimal treatment duration remains debated. Prior randomized trials have suggested shorter courses may be as effective as longer regimens in selected patients. This study analyzed real-world data from 67 Michigan hospitals to evaluate outcomes associated with short versus longer antibiotic courses in clinically stable hospitalized patients. The findings aim to inform guideline recommendations and clinical practice.
Data Highlights
| Outcome | Short-Course Group (3-4 days) | Longer-Course Group (Median 7 days) |
|---|---|---|
| Mortality | <1% | <1% |
| 30-day Readmission | 8%-9% | 8%-9% |
| Urgent Health Care Visits | Similar rates | Similar rates |
| Clostridioides difficile Infection | Rare | Rare |
| Antibiotic-Associated Adverse Events | Uncommon | Uncommon |
Key Findings
- Only about 10% of hospitalized pneumonia patients met eligibility for short-course therapy based on clinical stability by day 3.
- Short-course therapy was uncommon, with fewer than 10% of eligible patients receiving 3-4 days of antibiotics.
- Mortality was less than 1% and similar between short and longer antibiotic courses.
- Rates of 30-day readmission, urgent healthcare visits, and Clostridioides difficile infection did not differ significantly between groups.
- Antibiotic-associated adverse events were rare and occurred at similar rates regardless of treatment duration.
- Sensitivity analyses excluding patients with pre-hospital antibiotics did not alter results.
Clinical Implications
For hospitalized patients with community-acquired pneumonia who achieve clinical stability by day 3 and are not critically ill, shorter antibiotic courses appear to be as safe and effective as longer regimens. Clinicians should consider guideline recommendations favoring shorter durations in this select population to reduce antibiotic exposure. However, most hospitalized patients may not meet criteria for short-course therapy due to comorbidities or illness severity.
Conclusion
Shorter antibiotic courses in clinically stable hospitalized pneumonia patients are associated with comparable clinical outcomes to longer courses. These findings support guideline-endorsed shorter treatment durations in appropriate patients, although applicability is limited to a subset of hospitalized individuals.
Related Resources & Content
- Annals of Internal Medicine -- Short Antibiotics Match Outcomes in Pneumonia
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
